BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36876943)

  • 1. Translational Orthotopic Models of Glioblastoma Multiforme.
    El Meskini R; Atkinson D; Weaver Ohler Z
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36876943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors.
    El Meskini R; Iacovelli AJ; Kulaga A; Gumprecht M; Martin PL; Baran M; Householder DB; Van Dyke T; Weaver Ohler Z
    Dis Model Mech; 2015 Jan; 8(1):45-56. PubMed ID: 25431423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
    Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
    Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
    Wang W; Cho HY; Rosenstein-Sisson R; Marín Ramos NI; Price R; Hurth K; Schönthal AH; Hofman FM; Chen TC
    J Neurosurg; 2018 Mar; 128(3):695-700. PubMed ID: 28409734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma.
    Simões RV; Henriques RN; Cardoso BM; Fernandes FF; Carvalho T; Shemesh N
    Neuroimage Clin; 2022; 33():102932. PubMed ID: 35026626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthotopic brain tumor models derived from glioblastoma stem-like cells.
    Eyme KM; Sammarco A; Badr CE
    Methods Cell Biol; 2022; 170():1-19. PubMed ID: 35811093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
    Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
    Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice.
    Liu L; van Schaik TA; Chen KS; Rossignoli F; Borges P; Vrbanac V; Wakimoto H; Shah K
    Front Immunol; 2023; 14():1324618. PubMed ID: 38274817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
    Upton DH; Ziegler DS; Tsoli M
    Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma.
    Salphati L; Alicke B; Heffron TP; Shahidi-Latham S; Nishimura M; Cao T; Carano RA; Cheong J; Greve J; Koeppen H; Lau S; Lee LB; Nannini-Pepe M; Pang J; Plise EG; Quiason C; Rangell L; Zhang X; Gould SE; Phillips HS; Olivero AG
    Drug Metab Dispos; 2016 Dec; 44(12):1881-1889. PubMed ID: 27638506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
    Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly invasive human glioblastoma pre-clinical model for testing therapeutics.
    Xie Q; Thompson R; Hardy K; DeCamp L; Berghuis B; Sigler R; Knudsen B; Cottingham S; Zhao P; Dykema K; Cao B; Resau J; Hay R; Vande Woude GF
    J Transl Med; 2008 Dec; 6():77. PubMed ID: 19055779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
    Rahme GJ; Luikart BW; Cheng C; Israel MA
    Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.